| A miniaturized screening platform to identify novel regulators of extracellular matrix alignment CE Jones, JT Sharick, ST Sizemore, E Cukierman, AM Strohecker, ... Cancer research communications 2 (11), 1471-1486, 2022 | 5 | 2022 |
| Assessing Tracheal Health Using Optical Metabolic Imaging and Optical Coherence Tomography DA Gil, JT Sharick, UA Gamm, MA Choma, MC Skala Vanderbilt University, 2016 | | 2016 |
| Cellular Metabolic Heterogeneity In Vivo Is Recapitulated in Tumor Organoids JT Sharick, JJ Jeffery, MR Karim, CM Walsh, K Esbona, RS Cook, ... Neoplasia 21 (6), 615-626, 2019 | 61 | 2019 |
| Click chemistry functionalization of self-assembling peptide hydrogels JT Sharick, AJ Atieh, KJ Gooch, JL Leight Journal of biomedical materials research. Part A, 2022 | 5 | 2022 |
| Fluorescence lifetime imaging microscopy: fundamentals and advances in instrumentation, analysis, and applications R Datta, TM Heaster, JT Sharick, AA Gillette, MC Skala Journal of biomedical optics 25 (7), 071203-071203, 2020 | 555 | 2020 |
| Fluorescence Lifetime Measurements of NAD(P)H in Live Cells and Tissue AJ Walsh, AT Shah, JT Sharick, MC Skala Advanced Time-Correlated Single Photon Counting Applications, 435-456, 2015 | 9 | 2015 |
| Functional optical imaging of tracheal health (Conference Presentation) DA Gil, JT Sharick, UA Gamm, MA Choma, MC Skala Optical Techniques in Pulmonary Medicine II 10041, 10-10, 2017 | | 2017 |
| Imaging intratumoral metabolic heterogeneity AJ Walsh, JT Sharick, MC Skala Nature biomedical engineering 3 (5), 333-334, 2019 | 4 | 2019 |
| MEK activation modulates glycolysis and supports suppressive myeloid cells in TNBC DA Franklin, JT Sharick, PI Ericsson-Gonzalez, V Sanchez, PT Dean, ... JCI insight 5 (15), 2020 | 27 | 2020 |
| MEK activation modulates immunosuppressive MDSCs and metabolic phenotypes in TNBC DA Franklin, JT Sharick, PI Ericsson-Gonzalez, V Sanchez, PT Dean, ... Cancer Research 79 (13_Supplement), 1511-1511, 2019 | | 2019 |
| Metabolic heterogeneity in patient tumor-derived organoids by primary site and drug treatment JT Sharick, CM Walsh, CM Sprackling, CA Pasch, DL Pham, K Esbona, ... Frontiers in Oncology 10, 553, 2020 | 93 | 2020 |
| Optical metabolic imaging for monitoring tracheal health JT Sharick, DA Gil, MA Choma, MC Skala Imaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues IX …, 2016 | 1 | 2016 |
| Optical metabolic imaging measures early drug response in an allograft murine breast cancer model (Conference Presentation) JT Sharick, RS Cook, MC Skala Diagnosis and Treatment of Diseases in the Breast and Reproductive System …, 2017 | 1 | 2017 |
| Optical metabolic imaging of heterogeneous drug response in pancreatic cancer patient organoids JT Sharick, CM Walsh, CM Sprackling, CA Pasch, AA Parikh, ... bioRxiv, 542167, 2019 | 4 | 2019 |
| Patient-derived cancer organoid cultures to predict sensitivity to chemotherapy and radiation CA Pasch, PF Favreau, AE Yueh, CP Babiarz, AA Gillette, JT Sharick, ... Clinical Cancer Research 25 (17), 5376-5387, 2019 | 180 | 2019 |
| Personalized medicine in pancreatic cancer using cellular-resolution optical metabolic imaging JT Sharick, T Qian, JK Johnson, L Li, CA Pasch, DA Deming, AA Parikh, ... Cancer Research 78 (13_Supplement), 4100-4100, 2018 | | 2018 |
| Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models ML Schulte, A Fu, P Zhao, J Li, L Geng, ST Smith, J Kondo, RJ Coffey, ... Nature medicine 24 (2), 194-202, 2018 | 363 | 2018 |
| Predicting clinical response in breast cancer using cellular-resolution optical metabolic imaging JT Sharick, AJ Walsh, ME Sanders, I Meszoely, MA Hooks, MC Kelley, ... Cancer Research 76 (14_Supplement), 4241-4241, 2016 | | 2016 |
| Predicting patient response to therapy in pancreatic and breast cancer using optical metabolic imaging (Conference Presentation) JT Sharick, AJ Walsh, ME Sanders, MC Kelley, IM Meszoely, MA Hooks, ... Imaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues XV …, 2017 | | 2017 |
| Protein-bound NAD (P) H lifetime is sensitive to multiple fates of glucose carbon (Conference Presentation) JT Sharick, PF Favreau, AA Gillette, SM Sdao, MJ Merrins, MC Skala Biophysics, Biology and Biophotonics III: the Crossroads 10504, 1050403, 2018 | 1 | 2018 |
Melissa C. SkalaProf. of Biomedical Engineering, University of Wisconsin - Madison; Morgridge Institute for Research在 wisc.edu 的电子邮件经过验证
